FDA Adverse Event Injury Summary report: N

UNK

MDR report key: 853353 · Received May 17, 2007

Report

Report Number
1644019-2007-00013
Event Type
Injury
Date Received
May 17, 2007
Report Date
April 16, 2007
Manufacturer
ALCON - HOUSTON
Product Code
HQE
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

NO ALCON PRODUCT WAS IDENTIFIED AS THE CAUSE OF TASS PER THE SITE VISIT, AND THE VISIT REVEALED THAT THERE WERE MANY RECOMMENDED OPHTHALMIC PRACTICES THAT WERE NOT BEING FOLLOWED. THE AUDITOR CITED THE DISCREPANCIES AND MADE RECOMMENDATIONS TO COMPLY WITH RECOMMENDED PRACTICES. THE FACILITY STATED, THEY HAVE MADE MANY CHANGES IN THEIR CATARACT PROCEDURE PRACTICE, AFTER THE SITE VISIT AUDIT AND RECOMMENDATIONS WERE GIVEN TO THEM. THIS IS INCLUDED IN THE ACTION ITEM OF THE SITE VISIT. THEY HAVE PERFORMED SURGERY SEVERAL TIMES AND HAVE NOT HAD ANY CASES OF TASS SINCE THE SITE VISIT AND THE IMPLEMENTATION OF NEW PRACTICES.

Description of Event or Problem · 1

THE FACILITY HAS BEEN EXPERIENCING TASS, AND THEY DO NOT KNOW WHAT COULD BE SOURCE. NO PATIENT INFORMATION WAS PROVIDED, AND NO ADDITIONAL INFORMATION IS EXPECTED. A TASS SITE VISIT WAS PERFORMED IN 2007. THE NURSE CONSULTANT REVIEWED THEIR CATARACT PRACTICE PROCEDURE AND HAD THE FOLLOWING RECOMMENDATIONS. FOLLOW RECOMMENDED PRACTICES FOR CLEANING AND STERILIZING INTRAOCULAR SURGICAL INSTRUMENTS. REFRAIN FROM USING ENZYMATIC CLEANER. USE STERILE WATER FOR FINAL INSTRUMENT PROCESSING. CLEAN INSTRUMENTS AS SOON AS CASE IS COMPLETED. USE PRESERVATIVE FREE MEDICATIONS ONLY AT THE END OF THE CASE. USE PRESERVATIVE FREE MEDICATIONS INSIDE THE EYE. CONTINUE FLUSHING EYE AFTER BETADINE PLACED IN CUL DE SAC AT BEGINNING OF THE PROCEDURE. DISCONTINUE RE-USE OF SINGLE USE ITEMS. DECREASE NUMBER OF ITEMS THAT IOL COMES IN CONTACT WITH A CORRECT USAGE OF FORCEPS TO LOAD IOL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNK NONE HQE ALCON - HOUSTON UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 NA YR